KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in KalVista Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KALV is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 184
- +25 vs. Q4 2025
- Shares held
- 69.3M
- +4.82M (+7.5%) vs. Q4 2025
- Total value
- $1.39B
- +$353.2M (+33.9%) vs. Q4 2025
- New holders
- 41
- 64 more added
- Sold out
- 16
- 45 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 6,474,485 | $130.3M | 4.86% | −254,500−3.8% | Reduced |
| Frazier Life Sciences Management, L.P. | 4,961,108 | $99.9M | 2.57% | −78,759−1.6% | Reduced |
| Suvretta Capital Management, LLC | 4,768,712 | $96.0M | 2.60% | 00.0% | Unchanged |
| Tang Capital Management LLC | 4,573,530 | $92.1M | 4.68% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,795,897 | $76.4M | 0.00% | +41,749+1.1% | Added |
| Silverarc Capital Management, LLC | 2,876,407 | $57.9M | 6.82% | +449,289+18.5% | Added |
| Capital World Investors | 2,808,583 | $56.5M | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,136,940 | $43.0M | 0.07% | −146,826−6.4% | Reduced |
| State Street Corp | 1,955,844 | $39.4M | 0.00% | +44,153+2.3% | Added |
| Millennium Management LLC | 1,912,146 | $38.5M | 0.03% | −984,520−34.0% | Reduced |
| Vestal Point Capital, LP | 1,850,000 | $37.2M | 1.04% | −40,000−2.1% | Reduced |
| Parkman Healthcare Partners LLC | 1,835,506 | $36.9M | 3.83% | +66,998+3.8% | Added |
| Vanguard Capital Management LLC | 1,830,467 | $36.8M | 0.00% | +1,830,467 | New |
| Kynam Capital Management, LP | 1,820,954 | $36.7M | 2.33% | +10,000+0.6% | Added |
| Woodline Partners LP | 1,509,920 | $30.4M | 0.11% | −411,172−21.4% | Reduced |
| Octagon Capital Advisors LP | 1,450,000 | $29.2M | 3.23% | +176,667+13.9% | Added |
| Emerald Advisers, LLC | 1,264,023 | $25.4M | 0.81% | −76,472−5.7% | Reduced |
| Armistice Capital, LLC | 1,236,000 | $24.9M | 0.82% | +436,000+54.5% | Added |
| Elmind Capital, LP | 1,021,300 | $20.6M | 5.84% | +220,000+27.5% | Added |
| Geode Capital Management, LLC | 996,235 | $20.1M | 0.00% | +52,158+5.5% | Added |
| Squadron Capital Management LLC | 985,100 | $19.8M | 7.93% | +285,100+40.7% | Added |
| Spruce Street Capital LP | 897,681 | $18.1M | 4.34% | +509,713+131.4% | Added |
| Freestone Grove Partners LP | 882,906 | $17.8M | 0.13% | +249,887+39.5% | Added |
| Goldman Sachs Group Inc | 824,293 | $16.6M | 0.00% | −11,011−1.3% | Reduced |
| Emerald Mutual Fund Advisers Trust | 805,762 | $16.2M | 0.79% | −49,699−5.8% | Reduced |
| Great Point Partners LLC | 675,000 | $13.6M | 3.33% | −10,632−1.6% | Reduced |
| Bank of New York Mellon Corp | 584,347 | $11.8M | 0.00% | −110,828−15.9% | Reduced |
| Driehaus Capital Management LLC | 564,039 | $11.4M | 0.08% | +564,039 | New |
| Bank of America Corp | 555,628 | $11.2M | 0.00% | +165,815+42.5% | Added |
| Barclays PLC | 537,061 | $10.8M | 0.00% | −163,512−23.3% | Reduced |
| UBS Group AG | 515,650 | $10.4M | 0.00% | +143,657+38.6% | Added |
| Schroder Investment Management Group | 506,743 | $9.30M | 0.01% | −665,012−56.8% | Reduced |
| Morgan Stanley | 439,099 | $8.84M | 0.00% | −261,129−37.3% | Reduced |
| Catalio Capital Management, LP | 426,551 | $8.59M | 1.79% | +426,551 | New |
| Hennion & Walsh Asset Management, Inc. | 375,995 | $7.57M | 0.25% | +34,176+10.0% | Added |
| Northern Trust Corp | 363,694 | $7.32M | 0.00% | +11,721+3.3% | Added |
| Vanguard Portfolio Management LLC | 362,900 | $7.31M | 0.00% | +362,900 | New |
| SEB Asset Management AB | 351,305 | $7.07M | 0.03% | +351,305 | New |
| Charles Schwab Investment Management Inc | 323,451 | $6.51M | 0.00% | −918−0.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 315,537 | $6.35M | 0.05% | +9,657+3.2% | Added |
| HRT Financial LP | 286,916 | $5.78M | 0.01% | −1360.0% | Reduced |
| Jefferies Financial Group Inc. | 286,046 | $5.76M | 0.07% | +286,046 | New |
| Ishara Investments LP | 276,750 | $5.57M | 5.63% | +276,750 | New |
| Vanguard Fiduciary Trust Co | 276,391 | $5.56M | 0.00% | +276,391 | New |
| DAFNA Capital Management LLC | 267,402 | $5.38M | 1.22% | −89,400−25.1% | Reduced |
| Atom Investors LP | 245,993 | $4.95M | 0.35% | −30,120−10.9% | Reduced |
| Citigroup Inc | 244,261 | $4.92M | 0.00% | +233,490+2,167.8% | Added |
| Ameriprise Financial Inc | 229,984 | $4.63M | 0.00% | +195,055+558.4% | Added |
| F/M Investments LLC | 226,991 | $4.57M | 0.30% | −9,699−4.1% | Reduced |
| Blue Owl Capital Holdings LP | 215,000 | $4.33M | 1.16% | −145,000−40.3% | Reduced |
| FMR LLC | 187,848 | $3.78M | 0.00% | +76,041+68.0% | Added |
| Qube Research & Technologies Ltd | 180,314 | $3.63M | 0.01% | +180,314 | New |
| ExodusPoint Capital Management, LP | 177,274 | $3.57M | 0.04% | +157,213+783.7% | Added |
| Marshall Wace, LLP | 162,908 | $3.28M | 0.00% | +162,908 | New |
| Nan Fung Trinity (HK) Ltd | 154,522 | $3.11M | 0.34% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 153,459 | $3.09M | 0.00% | +153,459 | New |
| Squarepoint Ops LLC | 143,966 | $2.90M | 0.01% | +143,966 | New |
| Raymond James Financial Inc | 140,651 | $2.83M | 0.00% | +11,134+8.6% | Added |
| Trexquant Investment LP | 139,458 | $2.81M | 0.02% | +139,458 | New |
| NEXTBio Capital Management LP | 131,796 | $2.65M | 1.23% | 00.0% | Unchanged |
| Seven Fleet Capital Management LP | 128,487 | $2.59M | 0.81% | +80,075+165.4% | Added |
| Brevan Howard Capital Management LP | 125,049 | $2.42M | 0.02% | +65,902+111.4% | Added |
| Wellington Management Group LLP | 107,262 | $2.16M | 0.00% | −15,117−12.4% | Reduced |
| Nuveen, LLC | 106,864 | $2.15M | 0.00% | −265−0.2% | Reduced |
| Citadel Advisors LLC | 97,726 | $1.97M | 0.00% | +59,965+158.8% | Added |
| OrbiMed Advisors LLC | 94,400 | $1.90M | 0.04% | −288,000−75.3% | Reduced |
| Walleye Capital LLC | 79,666 | $1.60M | 0.01% | +79,666 | New |
| XTX Topco Ltd | 79,118 | $1.59M | 0.03% | +52,610+198.5% | Added |
| Invesco Ltd. | 75,282 | $1.52M | 0.00% | −2,582−3.3% | Reduced |
| Martingale Asset Management L P | 69,945 | $1.41M | 0.04% | +39,006+126.1% | Added |
| Swiss Life Asset Management Ltd | 21,885 | $1.38M | 0.01% | +21,885 | New |
| Campbell & CO Investment Adviser LLC | 64,249 | $1.29M | 0.07% | +64,249 | New |
| Creative Planning | 59,986 | $1.21M | 0.00% | +15,904+36.1% | Added |
| Rafferty Asset Management, LLC | 57,296 | $1.15M | 0.00% | −8,297−12.6% | Reduced |
| Birchview Capital, LP | 57,000 | $1.15M | 0.65% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 56,192 | $1.13M | 0.00% | −57−0.1% | Reduced |
| Swiss National Bank | 54,900 | $1.11M | 0.00% | 00.0% | Unchanged |
| CenterBook Partners LP | 53,264 | $1.07M | 0.06% | +53,264 | New |
| Panagora Asset Management Inc | 50,792 | $1.02M | 0.00% | −58,599−53.6% | Reduced |
| Virtus Investment Advisers, Inc. | 49,927 | $1.01M | 0.28% | +9,513+23.5% | Added |
| Rhumbline Advisers | 47,469 | $955.5K | 0.00% | +78+0.2% | Added |
| Susquehanna International Group, LLP | 46,760 | $941.3K | 0.00% | −25,135−35.0% | Reduced |
| Lisanti Capital Growth, LLC | 43,775 | $881.2K | 0.22% | +43,775 | New |
| Man Group plc | 42,576 | $857.1K | 0.00% | +25,130+144.0% | Added |
| Alps Advisors Inc | 41,149 | $828.3K | 0.00% | −355−0.9% | Reduced |
| Deutsche Bank AG | 38,857 | $782.2K | 0.00% | +3,766+10.7% | Added |
| AQR Capital Management LLC | 37,572 | $756.3K | 0.00% | +12,906+52.3% | Added |
| Quadrature Capital Ltd | 35,123 | $707.0K | 0.01% | +35,123 | New |
| Ikarian Capital, LLC | 35,119 | $706.9K | 0.10% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 34,743 | $699.4K | 0.00% | +7,021+25.3% | Added |
| Y-Intercept (Hong Kong) Ltd | 33,776 | $679.9K | 0.01% | +33,776 | New |
| Quarry LP | 33,750 | $679.4K | 0.14% | +33,750 | New |
| Quantinno Capital Management LP | 32,453 | $653.3K | 0.00% | +3,297+11.3% | Added |
| Evoke Wealth, LLC | 31,542 | $634.9K | 0.01% | −299−0.9% | Reduced |
| Price T Rowe Associates Inc | 29,367 | $592.0K | 0.00% | +6,249+27.0% | Added |
| Alliancebernstein L.P. | 33,580 | $542.3K | 0.00% | −6,440−16.1% | Reduced |
| Axq Capital, LP | 26,850 | $540.5K | 0.07% | +26,850 | New |
| Profund Advisors LLC | 25,660 | $516.5K | 0.02% | +1,268+5.2% | Added |
| Verition Fund Management LLC | 25,500 | $513.3K | 0.00% | +25,500 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 24,296 | $489.1K | 0.00% | +6,428+36.0% | Added |